Vahanian A, Beyersdorf F, Praz F, et al; ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur J Cardiothorac Surg. 2021 Oct 22;60(4):727-800. doi: 10.1093/ejcts/ezab389. PMID: 34453161.
Baumgartner H, De Backer J, Babu-Narayan SV, et al; ESC Scientific Document Group. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2021 Feb 11;42(6):563-645. doi: 10.1093/eurheartj/ehaa554. PMID: 32860028.
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021 Feb 2;143(5):e35-e71. doi: 10.1161/CIR.0000000000000932. Epub 2020 Dec 17. Erratum in: Circulation. 2021 Feb 2;143(5):e228. Erratum in: Circulation. 2021 Mar 9;143(10):e784. PMID: 33332149.
Definition, Etiology, Clinical FeaturesTop
Mixed aortic stenosis (AS) and aortic regurgitation (AR) refers to concomitant stenosis and regurgitation of the aortic valve.
Etiology: Congenital (most commonly a bicuspid aortic valve), degenerative, rheumatic disease, prior balloon valvuloplasty for AS in childhood, or prior mediastinal irradiation.
Clinical features are similar to other types of acquired aortic valve disease and depend on the dominant lesion (AS vs AR). The coexisting AR causes a louder systolic murmur by increasing transvalvular flow across the stenotic valve.
1. Surgery: The decision is made on an individual basis, taking into consideration the symptoms, transvalvular gradient, aortic valve area, and left ventricular size and function.
Indications: In patients with dominant stenosis, even if the symptoms are mild; in patients with dominant regurgitation in the case of severe symptoms or reduced left ventricular ejection fraction. In patients with postradiation disease, the most common indication for surgery is concomitant coronary artery disease.
2. Pharmacotherapy: Depends on the dominant lesion. Note that vasodilators used for AR may increase the transvalvular gradient of AS; agents that slow the heart rate (beta-blockers) may increase regurgitant volumes in AR.
3. Prevention of infective endocarditis: see Infective Endocarditis.
We would love to hear from you
Comments, mistakes, suggestions?